- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03287440
Rehabilitation for Patients With COPD (COPD Wellness)
Pilot Study of Rehabilitation in Safety-net Settings for Patients With COPD
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the course of COPD and improve outcomes, pulmonary rehabilitation is the one notable exception. However, implementation of this resource-intensive program in real-life settings, and in particular, for underserved communities, has proven to be challenging. Safety-net centers that serve primarily under-insured populations lack financial resources to provide pulmonary rehabilitation.
COPD Wellness, a 10-week low-intensity pulmonary rehabilitation program consisting of group and home exercise, education, and social support, was developed to address this gap. This intervention is targeted at patients with moderate to severe COPD (GOLD Class B-D) who receive care through a safety-net health system. To be impactful, risk factors for low adherence include both disease severity and socio-environmental factors, must be addressed. As merely having a pulmonary rehabilitation program will not automatically lead to improved outcomes.
As part of this study, an adherence strategy targeted at addressing unmet social needs to improve health will also be implemented. A Health Advocates program that links social needs screening with a tiered referral and linkage process to appropriate resources will be tested to see if adherence to COPD Wellness (exercise intervention) improves by addressing competing non-medical stressors.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94110
- Zuckerberg San Francisco General Hospital and Trauma Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: Are greater than or equal to 40 years
- Diagnosis: COPD Gold Stage Class B-D (symptomatic disease), COPD/Asthma overlap with symptoms
- Language: English
- Care Center: ZSFG, Community Health Center clinics, Federally Qualified Health Centers
- Availability: Able to participate in a 10-week, weekly course at the weekly scheduled time (can defer x 1)
Exclusion Criteria:
- Planning to move out of the area within the next year
- Eligible for and desire to go to full intensity pulmonary rehabilitation. Participant has Medicare Part A and B OR have San Francisco Health Plan. For those that met these criteria, we will assist with referral to program
- Resides in any kind of long-term care facilities that is NOT Laguna Honda or the Mental Health Rehabilitation Facility
- Has a diagnosis of interstitial lung disease, pulmonary fibrosis, or cystic fibrosis
- Active, chronic lung infection, such as tuberculosis
- A history of a pulmonary embolism in the year (12 months) prior to recruitment
- History of a myocardial infarction in the year (12 months) prior to recruitment
- In the 12 weeks prior to recruitment, has had history of unstable heart disease (including valve disease), heart failure, or uncontrolled irregular heart beat
Potential participants who have had the following will be re-assess for eligibility 6 weeks after the initial assessment:
- A pulmonary exacerbation or worsening of COPD/Asthma symptoms in the past 6 weeks
- History of an upper respiratory infection in the past 6 weeks
- History of an eye, chest, or abdominal surgery within the past 6 weeks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: COPD Wellness With Health Advocate
This arm will be given low-intensity pulmonary rehabilitation, COPD Wellness, for individuals with moderate-to-severe COPD with an additional assignment of a health advocate to address unmet social needs as an adherence strategy.
|
This is low-intensity pulmonary rehabilitation that incorporates exercise, nutrition, patient education, and a support group class.
The Zuckerberg San Francisco General (ZSFG) Hospital Health Advocates program links social needs screening with a tiered referral and linkage process to appropriate resources
|
Active Comparator: COPD Wellness
This arm will only be given low-intensity pulmonary rehabilitation, COPD Wellness, for individuals with moderate-to-severe COPD.
|
This is low-intensity pulmonary rehabilitation that incorporates exercise, nutrition, patient education, and a support group class.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline 6 Minute Walk Test at End of Intervention
Time Frame: End of Intervention, an average of 4 months
|
Standardized test to measure distance walked in 6 minutes
|
End of Intervention, an average of 4 months
|
Change from Baseline COPD Assessment Test (CAT) at End of Intervention
Time Frame: End of Intervention, an average of 4 months
|
Questionnaire assessing COPD symptoms and quality of life
|
End of Intervention, an average of 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline number of exacerbations of COPD at End of Intervention
Time Frame: End of Intervention, an average of 4 months
|
Exacerbation defined as a visit to an urgent care or emergency department for COPD, a hospitalization for COPD, or a prescription of an oral steroid for worsening COPD symptoms
|
End of Intervention, an average of 4 months
|
Change from Baseline number of exacerbations of COPD at 12 months
Time Frame: 12 months
|
Exacerbation defined as a visit to an urgent care or emergency department for COPD, a hospitalization for COPD, or a prescription of an oral steroid for worsening COPD symptoms
|
12 months
|
Change in baseline Smoking status at end of intervention
Time Frame: End of Intervention, an average of 4 months
|
Have you smoked a cigarette in the past 30 days
|
End of Intervention, an average of 4 months
|
Change in baseline Smoking status at 12 months
Time Frame: 12 months
|
Have you smoked a cigarette in the past 30 days
|
12 months
|
Change from baseline D-12 evaluation at end of intervention
Time Frame: End of Intervention, an average of 4 months
|
Evaluates dyspnea symptoms and increased ease of activities of daily living as related to COPD symptoms
|
End of Intervention, an average of 4 months
|
Change from baseline D-12 evaluation at 12 months
Time Frame: 12 months
|
Evaluates dyspnea symptoms and increased ease of activities of daily living as related to COPD symptoms
|
12 months
|
Change in baseline Patient Health Questionnaire (PHQ-)8 at End of Intervention
Time Frame: End of Intervention, an average of 4 months
|
Diagnoses of depressive disorders and depression severity
|
End of Intervention, an average of 4 months
|
Adherence
Time Frame: Assessed during 10-week COPD Wellness Intervention
|
Number of classes attended by the participant
|
Assessed during 10-week COPD Wellness Intervention
|
Change from Baseline 6 Minute Walk Test at 12 months
Time Frame: Baseline and 12 months
|
Standardized test to measure distance walked in 6 minutes
|
Baseline and 12 months
|
Change from Baseline COPD Assessment Test (CAT) at 12 months
Time Frame: Baseline, 12 months
|
Measure of COPD symptoms and quality of life
|
Baseline, 12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Neeta Thakur, MD, MPH, University of California, San Francisco
Publications and helpful links
General Publications
- Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med. 2000 Aug 15;109(3):207-12. doi: 10.1016/s0002-9343(00)00472-1.
- Baumann HJ, Kluge S, Rummel K, Klose H, Hennigs JK, Schmoller T, Meyer A. Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial. Respir Res. 2012 Sep 27;13(1):86. doi: 10.1186/1465-9921-13-86.
- Selzler AM, Simmonds L, Rodgers WM, Wong EY, Stickland MK. Pulmonary rehabilitation in chronic obstructive pulmonary disease: predictors of program completion and success. COPD. 2012 Aug;9(5):538-45. doi: 10.3109/15412555.2012.705365.
- Fischer MJ, Scharloo M, Abbink JJ, van 't Hul AJ, van Ranst D, Rudolphus A, Weinman J, Rabe KF, Kaptein AA. Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med. 2009 Oct;103(10):1564-71. doi: 10.1016/j.rmed.2008.11.020. Epub 2009 May 29.
- Rochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, Spruit MA, Masefield S, Casaburi R, Clini EM, Crouch R, Garcia-Aymerich J, Garvey C, Goldstein RS, Hill K, Morgan M, Nici L, Pitta F, Ries AL, Singh SJ, Troosters T, Wijkstra PJ, Yawn BP, ZuWallack RL; ATS/ERS Task Force on Policy in Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1373-86. doi: 10.1164/rccm.201510-1966ST.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-19967
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on COPD Wellness
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States
-
China-Japan Friendship HospitalNot yet recruitingChronic Obstructive Pulmonary Disease
-
University of Texas at AustinCompleted
-
University of Texas at AustinCompletedHealthy | Chronic Pain | Stress, PsychologicalUnited States
-
Mayo ClinicCompletedInflammatory Bowel Diseases | Crohn Disease | Ulcerative ColitisUnited States
-
Bournemouth UniversityRoyal Bournemouth and Christchurch Hospitals NHS Foundation Trust; Oomph! Wellness and other collaboratorsWithdrawnFrail Elderly Syndrome | Frailty | Sedentary Behavior | Life Style Induced Illness | Lifestyle, Sedentary
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive
-
University of Texas at AustinCompletedHealthy | Rheumatoid Arthritis | Chronic Pain | Stress | PsychologicalUnited States
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedObesity | SchizophreniaBrazil
-
NHS Greater Glasgow and ClydeUniversity of GlasgowUnknownChronic Obstructive Pulmonary DiseaseUnited Kingdom